Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918433 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
The FEV1 at the beginning of PORT was an independent significant prognostic factor in patients with NSCLC who received PORT. Considering this analysis was limited to only patients receiving PORT, further studies are warranted to compare the survival effect of postoperative pulmonary function between groups with/without PORT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hwanik Kim, Yves A. Lussier, O Kyu Noh, Haiquan Li, Young-Taek Oh, Jaesung Heo,